These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


317 related items for PubMed ID: 7594841

  • 21. Twelve-year experience with Carpentier-Edwards PERIMOUNT pericardial valve in the mitral position: a multicenter study.
    Marchand M, Aupart M, Norton R, Goldsmith IR, Pelletier C, Pellerin M, Dubiel T, Daenen W, Casselman F, Holden M, David TE, Ryba EA.
    J Heart Valve Dis; 1998 May; 7(3):292-8. PubMed ID: 9651842
    [Abstract] [Full Text] [Related]

  • 22. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I, Lip GY, Mukundan S, Rosin MD.
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [Abstract] [Full Text] [Related]

  • 23. Carpentier-Edwards supra-annular bioprosthesis in the aortic position. Has altered design affected performance?
    Wilson ES, Jamieson MP.
    J Heart Valve Dis; 1996 Jan; 5(1):40-4. PubMed ID: 8834724
    [Abstract] [Full Text] [Related]

  • 24. [Long-term results of isolated mitral valve replacement using bioprosthesis].
    Yao H, Miyamoto T, Murata H.
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Jun; 41(6):969-74. PubMed ID: 8336048
    [Abstract] [Full Text] [Related]

  • 25. Five-year evaluation of the Carpentier-Edwards porcine bioprosthesis.
    Jamieson WR, Pelletier LC, Janusz MT, Chaitman BR, Tyers FO, Miyagishima RT.
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):324-33. PubMed ID: 6381888
    [Abstract] [Full Text] [Related]

  • 26. [Surgical results of valve replacement with porcine bioprostheses].
    Saigenji H, Toyohira H, Shimokawa S, Moriyama Y, Watanabe S, Yamashita T, Yamaoka A, Yuda T, Toda R, Taira A.
    Nihon Kyobu Geka Gakkai Zasshi; 1996 May; 44(5):634-40. PubMed ID: 8964992
    [Abstract] [Full Text] [Related]

  • 27. Eighteen-year follow up after Hancock II bioprosthesis insertion.
    Legarra JJ, Llorens R, Catalan M, Segura I, Trenor AM, de Buruaga JS, Rabago G, Sarralde A.
    J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
    [Abstract] [Full Text] [Related]

  • 28. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
    Ruel M, Kulik A, Rubens FD, Bédard P, Masters RG, Pipe AL, Mesana TG.
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
    [Abstract] [Full Text] [Related]

  • 29. Is a bioprosthesis preferable in tricuspid valve replacement?
    Hayashi J, Saito A, Yamamoto K, Watanabe H, Ohzeki H, Eguchi S.
    Thorac Cardiovasc Surg; 1996 Oct; 44(5):230-3. PubMed ID: 8948549
    [Abstract] [Full Text] [Related]

  • 30. Double valve replacement with the Carpentier-Edwards pericardial valve: 10-year results.
    Aupart MR, Babuty DG, Guesnier L, Meurisse YA, Sirinelli AL, Marchand MA.
    J Heart Valve Dis; 1996 May; 5(3):312-6. PubMed ID: 8793683
    [Abstract] [Full Text] [Related]

  • 31. The Hancock II porcine bioprosthesis. A preliminary report.
    Bortolotti U, Milano A, Mazzucco A, Guerra F, Magni A, Santini F, Gallucci V.
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):415-20. PubMed ID: 2918737
    [Abstract] [Full Text] [Related]

  • 32. Performance of the Carpentier-Edwards SAV and Hancock-II porcine bioprostheses in aortic valve replacement.
    Jamieson WR, David TE, Feindel CM, Miyagishima RT, Germann E.
    J Heart Valve Dis; 2002 May; 11(3):424-30. PubMed ID: 12056738
    [Abstract] [Full Text] [Related]

  • 33. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?
    Alsoufi B, Manlhiot C, McCrindle BW, Canver CC, Sallehuddin A, Al-Oufi S, Joufan M, Al-Halees Z.
    Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085
    [Abstract] [Full Text] [Related]

  • 34. [Influence of the valve position on the complications related to pericardial Carpentier-Edwards valve after 8 years].
    Aupart M, Dreyfus X, Meurisse Y, May MA, Sirinelli A, Marchand M.
    Arch Mal Coeur Vaiss; 1995 Jul; 88(7):967-71. PubMed ID: 7487327
    [Abstract] [Full Text] [Related]

  • 35. The Carpentier-Edwards supraannular porcine bioprosthesis. A new generation tissue valve with excellent intermediate clinical performance.
    Jamieson WR, Munro AI, Miyagishima RT, Burr LH, Gerein AN, Janusz MT, Tyers GF, Allen P.
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):652-66. PubMed ID: 3172812
    [Abstract] [Full Text] [Related]

  • 36. Long-term results with the Xenomedica porcine bioprosthesis in the mitral position.
    Santini F, Auriemma S, Casali G, Rossi A, Lusini M, Mazzucco A.
    J Heart Valve Dis; 2001 Nov; 10(6):789-94. PubMed ID: 11767188
    [Abstract] [Full Text] [Related]

  • 37. The last generation of pericardial valves in the aortic position: ten-year follow-up in 589 patients.
    Aupart MR, Sirinelli AL, Diemont FF, Meurisse YA, Dreyfus XB, Marchand MA.
    Ann Thorac Surg; 1996 Feb; 61(2):615-20. PubMed ID: 8572776
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Excellent durability of the Hancock porcine bioprosthesis in the tricuspid position. A sixteen-year follow-up study.
    Kawachi Y, Tominaga R, Hisahara M, Nakashima A, Yasui H, Tokunaga K.
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1561-6. PubMed ID: 1453721
    [Abstract] [Full Text] [Related]

  • 40. A 25-year experience with Carpentier-Edwards Perimount in the mitral position.
    Ayegnon KG, Aupart M, Bourguignon T, Mirza A, May MA, Marchand M.
    Asian Cardiovasc Thorac Ann; 2011 Feb; 19(1):14-9. PubMed ID: 21357312
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.